J&J lowers its profit expectation and cancels its COVID vaccine sales forecastby Madhu Sahu April 19, 2022 0 After forecasting as much as $3.5 billion in sales for its COVID-19 vaccine, Johnson & Johnson (JNJ.N) lowered its full-year ...